Artemid supports Biotech Dental
The Artemid Senior Loan III fund is providing €20 million in financing that will enable the company to continue its international growth, particularly in the United States where the company has just acquired IDS, the last major independent distributor of dental implants.
Biotech Dental’s strategy is based on continuous innovation in both software and digital manufacturing processes.
This technological culture has enabled the group to build an offer of high quality products at affordable prices, 100% “Made in France”, in their manufacturing centers in the Arve Valley (Rhône-Alpes) and Salon-de-Provence, where its head office is also located.
The funds in the Artemid range are managed by the asset management company CAPZA as well as a third party portfolio management company and advised by Artemid SAS, a joint subsidiary of CAPZA and Amiral Gestion. Artemid SAS is a financial investment advisor (conseiller en investissement financier – CIF) registered at the ORIAS under the number 14003497 since 5/28/2014.
-
14Jan’ 2026CAPZA Exits Novarc After Driving International ExpansionCAPZA announces its exit from Novarc, after successfully supporting the Group’s strategic growth since 2021.Read more -
12Jan’ 2026Artemid completes first deal in ItalyArtemid participates in a senior debt financing to support BV Tech in its new phase of growth.Read more -
11Dec’ 2025Record Fundraising of Over €1 Billion for the Artemid Senior Loans StrategyCAPZA announces the successful closing of Artemid Senior Loan IV (ASL IV).Read more -
9Dec’ 2025Myrium welcomes CAPZA as a reference partnerMyrium opens a new chapter of growth by welcoming CAPZA as a reference partner.Read more